InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+7.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Shannon John Patrick Jr, 管理人员. Officer active across 2 companies, notably Xeris Pharmaceuticals INC. In total, 15 disclosures have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €270k. History available since 11 November 2021. The latest transaction was filed on 1 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Shannon John Patrick Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
36,645 股@ US$8.080.013% mcap20.9% 占其流量Common StockSEC:0001867096-26-000073:0
478,436 股0Common StockSEC:0001553595-26-000004:0
24,907 股@ US$7.076615.5% 占其流量Common StockSEC:0001553595-26-000002:0
8,970 股@ US$1.551.5% 占其流量Common StockSEC:0001553595-25-000004:0
36,918 股@ US$5.3821.4% 占其流量Common StockSEC:0001867096-25-000124:0
110,750 股@ US$3.5653.4% 占其流量Common StockSEC:0001867096-25-000026:0
39,443 股@ US$3.6119.5% 占其流量Common StockSEC:0001867096-25-000015:0
250,000 股0Common StockSEC:0001867096-24-000145:0
750,000 股0Common StockSEC:0001867096-24-000017:0
30,769 股@ US$1.6386.5% 占其流量Common StockSEC:0001867096-23-000145:0
标准退出：2024年2月15日 (T+90)
750,000 股0Common StockSEC:0001867096-23-000024:0
250,000 股0Common StockSEC:0001867096-22-000008:0
40,000 股@ US$2.08757.5% 占其流量Common StockSEC:0001867096-21-000077:0
标准退出：2022年2月9日 (T+90)
70,496 股Common StockSEC:0000899243-21-039333:0
70,496 股Common StockSEC:0000899243-21-039242:0
15 条申报中的 15 条
About Shannon John Patrick Jr
Shannon John Patrick Jr is a Dirigeant at Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals INC, both listed on XNAS. He has 14 filings in total, and across the 14 sampled filings, buys amount to EUR 119133 and sells to EUR 150587, over the period from 2021-10-05 to 2026-02-02; the modal transaction nature is Attribution.
